CEO & Director Yes. Well, thanks for having me today. Yes. So we are, if you will, a small molecule precision medicines company really focused on diseases that really haven't seen precision before like kidney disease. There's over 800 million people in the world that suffer from kidney disease. It's the ninth leading cause of death globally. Question-and-Answer Session I guess to start, can you provide an introduction to the company and walk us through where Maze stands today with your lead assets, 828 in A ...